Overview
SII Q-VAC Vaccine is a quadrivalent vaccine developed by Serum Institute of India (SII) to provide active immunization against four strains of human papillomavirus (HPV): types 6, 11, 16, and 18. These HPV types are associated with the majority of cervical cancers and genital warts. The vaccine is designed to help prevent HPV-related diseases in individuals prior to exposure to the virus.





